Evidence map›Paper›PMID 38878265›Full record

ArticleEuropean journal of public health2024

Disentangling the value equation: a step forward in value-based healthcare.

Borja García-Lorenzo, Itxaso Alayo, Arantzazu Arrospide, Ania Gorostiza, Ane Fullaondo, VOICE Study Group

Registry-linked trialAbstract read
In one paragraph

Article in European journal of public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04960735 (Value-based Healthcare for Outcomes in Breast and Lung Cancer in Europe), which is not on this map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04960735 nacompletednot on this map

Value-based Healthcare for Outcomes in Breast and Lung Cancer in Europe

TypeinterventionalSponsorBiosistemak Institute for Health Systems ResearchRan2019 to 2023Enrolled1,007ConditionsBreast Cancer, Lung CancerArmsVOICE intervention
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Borja García-LorenzoBiosistemak Institute for Health Systems Research, Torre del Bilbao Exhibition Centre, Barakaldo, Basque Country, Spain.ORCID 0000-0002-6546-4186
Itxaso AlayoBiosistemak Institute for Health Systems Research, Torre del Bilbao Exhibition Centre, Barakaldo, Basque Country, Spain.ORCID 0000-0002-7333-3450
Arantzazu ArrospideMinistry of Health of the Basque Government, Vitoria-Gasteiz, Spain.ORCID 0000-0003-3537-6588
Ania GorostizaBiosistemak Institute for Health Systems Research, Torre del Bilbao Exhibition Centre, Barakaldo, Basque Country, Spain.ORCID 0000-0002-9747-5816
Ane FullaondoBiosistemak Institute for Health Systems Research, Torre del Bilbao Exhibition Centre, Barakaldo, Basque Country, Spain.ORCID 0000-0002-2921-0226
VOICE Study Group

Funding

Value-Based Healthcare for Outcomes in Breast and Lung Cancer in Europe
6 · The paper itself

Abstract

backgroundThe value equation of value-based healthcare (VBHC) as a single figure remains ambiguous, closer to a theoretical framework than a useful tool for decision making. The challenge lies in the way patient-centred outcomes (PCOs) might be combined to produce a single value of the numerator. This paper aims to estimate the weights of PCOs to provide a single figure in the numerator, which ultimately will allow a VBHC figure to be reached.

methodsA cohort of patients diagnosed with breast cancer (n = 690) with a 6-month follow-up recruited in 2019-20 across six European hospitals was used. Patient-reported outcomes (PROs), clinical-related outcomes (CROs), and clinical and socio-demographic variables were collected. The numerator was defined as a composite indicator of the PCOs (CI-PCO), and regression analysis was applied to estimate their weights and consequently arrive at a single figure.

resultsPain showed as the highest weight followed by physical functioning, emotional functioning, and ability to work, and then by a symptom, either arm or breast. PCOs weights were robust to sensitivity analysis. The CI-PCO value was found to be more informative than the health-related quality of life (HRQoL) value.

conclusionsTo the best of our knowledge, this is the first research to combine the PCOs proposed by ICHOM to provide a single figure in the numerator of the value equation. This figure shows a step forward in VBHC to reach a holistic benchmarking across healthcare centres and a value-based payment. This research might also be applied in other medical conditions as a methodological pathway.

Indexed as

Breast NeoplasmsAdultAgedCohort StudiesEuropeFemaleHumansMiddle AgedPatient Reported Outcome MeasuresQuality of LifeValue-Based Health Care

Identifiers

PMID38878265
PMCPMC11293829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.